Skip to Main Content

Paper Details

Serum Prolactin Level to Tumor Size Ratio as a Potential Parameter for Preoperative Differentiation of Prolactinomas from Hyperprolactinemia-Causing Non-functional Pituitary Adenomas.
World Neurosurg
3
2022
Hyperprolactinemia, NFPAs, Non-functional Pituitary Adenomas, PDR1, PDR2, PRL, Prolactinomas, Serum Prolactin, dopamine, hyperprolactinemia, non-functioning pituitary adenomas, patients, pituitary lesions, prolactin, prolactinomas, serum PRL, serum prolactin, tumor
Author NameAffiliation
Sang Duk HongSamsung Medical Center, Sungkyunkwan University School of Medicine
Jung Won ChoiSamsung Medical Center, Sungkyunkwan University School of Medicine
Ho Jun SeolSamsung Medical Center, Sungkyunkwan University School of Medicine
Ho Jun SeolSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Do-Hyun NamSamsung Medical Center, Sungkyunkwan University School of Medicine
Jung-Il LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Jung-Il LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Doo-Sik KongSamsung Medical Center, Sungkyunkwan University School of Medicine
Doo-Sik KongSamsung Medical Center, Sungkyunkwan University School of Medicine
  • 1 - 10

Datasets

Release 1.2